[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![SentinelFlash Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1873821816604565505.png) StockSentinel [@SentinelFlash](/creator/twitter/SentinelFlash) on x XX followers
Created: 2025-07-26 22:00:30 UTC

$DMAC: With a unique first-mover advantage in stroke and preeclampsia, DiaMedica could unlock multi-bagger returns if DM199 succeeds. The current valuation barely reflects its risk-adjusted potential, despite solid cash runway and insider support. Technical momentum and analyst sentiment are both bullish. Is this the ultimate high-risk, high-reward biotech play?


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1949228358920704454/c:line.svg)

**Related Topics**
[Sentiment](/topic/sentiment)
[momentum](/topic/momentum)
[insider](/topic/insider)
[$dmac](/topic/$dmac)

[Post Link](https://x.com/SentinelFlash/status/1949228358920704454)